Senseonics Holdings Inc 2025年季度报告

FORM10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the Quarterly Period EndedJune30,2025or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934For the transition period from ______ to ______Commission file number:001-37717 Senseonics Holdings, Inc.(Exact name of registrant as specified in its charter) (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Securities registered pursuant to Section 12(b) of theSecurities Exchange Act of 1934: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of theSecurities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to filesuch reports), and (2) has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorterperiod that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, asmaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Largeacceleratedfiler☐Acceleratedfiler☐Non-accelerated filer☒Smallerreportingcompany☒Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transitionperiod for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the ExchangeAct.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ There were814,680,910shares of common stock, par value $0.001, outstanding as of August 1, 2025. TABLE OF CONTENTS PART I: Financial Information ITEM 1:Financial Statements Condensed Consolidated Balance Sheets as of June 30, 2025 (Unaudited) and December 31,20243Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss forthethree and six months ended June30,2025 and 20244Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)for the three and six months ended June 30, 2025 and 20245Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June30, 2025 and 20246Notes to Unaudited Condensed Consolidated Financial Statements7ITEM 2:Management’s Discussion and Analysis of Financial Condition and Results ofOperations25ITEM 3:Quantitative and Qualitative Disclosures About Market Risk36ITEM 4:Controls and Procedures36PART II:Other Information36ITEM 1:Legal Proceedings36ITEM 1A: Risk Factors37ITEM 2:Unregistered Sales of Equity Securities and Use of Proceeds43ITEM 3:Defaults Upon Senior Securities43ITEM 4:Mine Safety Disclosures43ITEM 5:Other Information43ITEM 6:Exhibits44SIGNATURES45 Senseonics Holdings, Inc.Condensed Consolidated Balance Sheets(in thousands, except share and per share data) Senseonics Holdings, Inc. The accompanying notes are an integral part of these unaudited condensed consolidated financialstatements. Senseonics Holdings, Inc. Senseonics Holdings, Inc. Notes to Unaudited Condensed Consolidated Financial Statements 1.Organization and Nature of Operations Senseonics Holdings, Inc., a Delaware corporation, is a medical technology companyfocused on the development and manufacturing of long-term, implantable continuous glucosemonitoring (“CGM”) systems to improve the lives of people with diabetes by enhancing their abilityto manage their disease with relative ease and accuracy. Senseonics, Incorporated is a wholly owned subsidiary of Senseonics Holdings, Inc. and wasoriginally incorporated on October 30, 1996, and commenced operations on January 15, 1997. EonCare Services, LLC and Eon Management Services, LLC are wholly owned subsidiaries ofSenseonics, Incorporated formed in April 2024 and July 2024, respectively. Senseonics Holdings, Inc.and its consolidated subsidiaries and affiliated entities, including its consolidated variable interestentities (“VIEs”) are hereinafter collectively referred to as the “Company”, unless otherwise indicatedor the context otherwise requires. 2.Liquidity and Capital Resources From its founding in 1996 until 2010, the Company has devoted substantially all of itsresources to researching various sensor technologies and platforms. Beginning in 2010, the Companynarrowed its focus to developing and refining a commercially viable glucose monitoring system.Since our inception, we have incurred significant net l